Oral Antibiotics for Pneumonia with WBC 15
For community-acquired pneumonia with a WBC of 15 (indicating moderate severity), start with high-dose amoxicillin 1 gram every 8 hours OR amoxicillin-clavulanate 2 grams every 12 hours as first-line therapy, adding azithromycin 500 mg on day 1 then 250 mg daily for 4 days if atypical pathogens are suspected. 1
Severity Assessment and Antibiotic Selection
A WBC count of 15 indicates moderate severity pneumonia requiring appropriate oral antibiotic coverage. The choice depends on several clinical factors:
For Outpatient Community-Acquired Pneumonia (Low-Moderate Severity)
Beta-lactam monotherapy options:
- Amoxicillin 500 mg-1 gram every 8 hours is the preferred first-line agent for typical bacterial pneumonia, particularly Streptococcus pneumoniae 1
- Amoxicillin-clavulanate 1-2 grams every 12 hours provides broader coverage including beta-lactamase producing organisms 1
- Ampicillin-sulbactam 375-750 mg every 12 hours is an alternative beta-lactam/beta-lactamase inhibitor combination 1
Fluoroquinolone monotherapy options (if beta-lactams contraindicated):
- Levofloxacin 750 mg once daily provides excellent coverage against both typical and atypical pathogens and can be used as monotherapy 1, 2, 3
- Moxifloxacin 400 mg once daily is equally effective as monotherapy 1
When to Add Atypical Coverage
Add a macrolide to beta-lactam therapy if:
- Patient has risk factors for atypical pathogens (Mycoplasma, Chlamydophila, Legionella)
- Clinical presentation suggests atypical pneumonia (gradual onset, dry cough, extrapulmonary symptoms)
Macrolide options:
- Azithromycin 500 mg on day 1, then 250 mg daily for 4 days (total 5-day course) 1, 4, 5
- Clarithromycin 500 mg every 12 hours 1
Treatment Duration
- 5-7 days for most cases of community-acquired pneumonia treated with appropriate antibiotics 1
- 3-5 days for azithromycin when used for atypical coverage 1, 4, 5
Clinical Algorithm
Assess severity: WBC 15 suggests moderate severity; confirm patient is appropriate for oral therapy (no septic shock, adequate oxygenation, able to take oral medications) 1
Choose initial regimen:
Reassess at 48-72 hours: Expect clinical improvement (decreased fever, improved symptoms) 1
Critical Pitfalls to Avoid
Fluoroquinolone cautions:
- Avoid empiric fluoroquinolones in areas with tuberculosis risk, as they may delay TB diagnosis and promote resistance 1
- Be aware of QT prolongation risk with levofloxacin and moxifloxacin, especially in elderly patients or those with cardiac conditions 6
- Consider cardiac risk factors before prescribing fluoroquinolones, including prolonged QT interval, electrolyte abnormalities, and concurrent QT-prolonging medications 6
Azithromycin warnings:
- Monitor for serious allergic reactions including anaphylaxis and Stevens-Johnson syndrome, though rare 6
- Discontinue immediately if hepatotoxicity signs develop (abnormal liver function, jaundice) 6
- Be aware of Clostridium difficile risk with all antibiotics, including azithromycin 6
Treatment failure considerations: